94 related articles for article (PubMed ID: 8704613)
1. [The effect of new synthetic prostanoids on the aggregation activity of human thrombocytes].
Petrukhina GN; Makarova VA; FReĭmanis IaF; Lozha EV
Eksp Klin Farmakol; 1995; 58(6):45-8. PubMed ID: 8704613
[TBL] [Abstract][Full Text] [Related]
2. [The effect of fluorinated prostaglandins on platelet aggregation].
Lakin KM; Makarov VA; Kovalev SG; Petrukhina GN; Serkov IV; Golovanova NK; Bezuglov VV
Eksp Klin Farmakol; 1994; 57(2):39-41. PubMed ID: 8205047
[TBL] [Abstract][Full Text] [Related]
3. [Antiaggregation activity of various synthetic prostaglandins].
Kudriashov SA; Geling NG; Mel'nikova VI; Pivnitskiĭ KK
Biull Eksp Biol Med; 1982 Nov; 94(11):7-9. PubMed ID: 6758877
[No Abstract] [Full Text] [Related]
4. [The effect of new synthetic prostanoids on the indices of the blood coagulation system].
Petrukhina GN; Makarov VA; Freĭmanis IaF; Lozha EV; Sirotenko AV
Eksp Klin Farmakol; 1995; 58(5):37-40. PubMed ID: 8704588
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic and vasodilating effects of OP-41483, a prostacyclin derivative.
Kinjo O; Kusaba A; Uesato T; Shiroma H; Koja K; Kina M; Kuniyoshi Y; Iha K; Shiohira T; Kawabata T
Int Angiol; 1987; 6(3):279-85. PubMed ID: 3329206
[TBL] [Abstract][Full Text] [Related]
6. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
[TBL] [Abstract][Full Text] [Related]
7. The effect of "xanthinol niacinate" on platelet aggregation.
Balkuv S; Akman N; Ulutin ON
New Istanbul Contrib Clin Sci; 1967; 9(2):49-51. PubMed ID: 16300148
[No Abstract] [Full Text] [Related]
8. [The antiaggregant activity of the synthetic antioxidant emoxipin].
Stoliarov VA; Repin AN; Markov VA
Eksp Klin Farmakol; 1993; 56(2):35-6. PubMed ID: 8348036
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet aggregation and white thrombus formation by prostaglandin analogue ONO-747.
Ojima M; Fujita K
Adv Prostaglandin Thromboxane Res; 1976; 2():781-5. PubMed ID: 983877
[No Abstract] [Full Text] [Related]
10. A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activity.
Gurbel PA; Bliden KP
Platelets; 2003; 14(7-8):481-3. PubMed ID: 14713517
[No Abstract] [Full Text] [Related]
11. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom.
Lopez-Johnston JC; de Bosch N; Scannone H; Rodríguez-Acosta A
Ann Hematol; 2007 Dec; 86(12):879-85. PubMed ID: 17891398
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
13. [The effect of melatonin on thrombocyte aggregation in healthy subjects].
Evsiukova EV; Petrishchev NN
Fiziol Cheloveka; 1998; 24(6):122-5. PubMed ID: 9929964
[No Abstract] [Full Text] [Related]
14. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
[TBL] [Abstract][Full Text] [Related]
15. Changes in platelet response to adenosine 5'-diphosphate caused by verapamil.
Walkowiak B; Koziołkiewicz W; Michalec L; Pawłowska Z; Krzesłowska J; Cierniewski CS
Pol J Pharmacol; 1996; 48(3):303-5. PubMed ID: 9112667
[TBL] [Abstract][Full Text] [Related]
16. [The action of the alkanol ammonium salts of aroxyacetic acids on the thrombocyte aggregation process].
Kazimirovskaia VB; Semenova NV; Moskvitina LT; Nepsha VD; Novikova NV; Voronkov MG
Eksp Klin Farmakol; 1995; 58(3):37-40. PubMed ID: 7663294
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet activity of inositol hexaphosphate (IP6).
Vucenik I; Podczasy JJ; Shamsuddin AM
Anticancer Res; 1999; 19(5A):3689-93. PubMed ID: 10625941
[TBL] [Abstract][Full Text] [Related]
19. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
[TBL] [Abstract][Full Text] [Related]
20. [Methodological approaches to restoring the antiaggregation properties of the vascular wall].
Baluda VP; Baluda MV; Deianov DV; Lukoianova TI; Makarov VA
Patol Fiziol Eksp Ter; 1987; (4):51-4. PubMed ID: 3684337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
